Trials / Completed
CompletedNCT00358553
A Crossover Study Assessing the Pharmacokinetics, Pharmacodynamics, and Safety of Recombinant Human Insulin
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Baxter Healthcare Corporation · Industry
- Sex
- Male
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the pharmacokinetics, pharmacodynamics, and safety of recombinant human insulin. The study will consist of 2 phases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Insulin |
Timeline
- First posted
- 2006-08-01
- Last updated
- 2007-03-13
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00358553. Inclusion in this directory is not an endorsement.